Screen Time Linked to Sleep Disruptions, Depression in Teens
Excessive screen time in adolescents disrupts sleep, increasing the risk of depression—especially among girls.
Tag: sleep apneas
All
Latest
Screen Time Linked to Sleep Disruptions, Depression in Teens
Excessive screen time in adolescents disrupts sleep, increasing the risk of depression—especially among girls.
Read More
Adenotonsillectomy Improved Pediatric Sleep-disordered Breathing
Adenotonsillectomy was tied to a 32% reduction in medical visits and a 48% reduction in prescription use among children with mild sleep-disordered breathing.
Read More
Daytime Sleepiness Tied to Greater Dementia Risk for Female Seniors
A study published in Neurology found that women in their 80s who experienced increasing daytime sleepiness over five years had double the risk of developing dementia.
Read More
CPAP Reduces Heart-related Mortality Up to 55%
A worldwide study of over one million patients with sleep apnea provides the strongest evidence to date that CPAP therapy not only alleviates OSA symptoms but can also prolong life.
Read More
54% of Americans Want Daylight Saving Time Ended
As the annual “spring forward” to observe daylight saving time approaches on March 9, new Gallup polling data reveals a majority of Americans want to eliminate the practice.
Read More
Global Sleep Study Reveals the Impact of Poor Sleep
Results from ResMed’s fifth annual Global Sleep Study reveal the toll that poor sleep takes on health, work, and relationships.
Read More
Diabetic Patients With Sleep Apnea Face Higher Death Risk
Diabetic patients with severe obstructive sleep apnea showed a 58% increase in all-cause mortality.
Read More
VGM Group Acquires SleepGlad, Provider of Remote Mask Fitting Tech
VGM Group Inc announced the acquisition of SleepGlad, maker of a cloud-based 3D mask-fitting platform for CPAP and noninvasive ventilation.
Read More
Patch-based Home Sleep Test Found Comparable to In-Lab PSG
A study demonstrates comparable performance between the wireless, patch-based sleep test system and in-lab polysomnography for sleep staging and respiratory event detection.
Read More
FDA Greenlights Phase 2 Trial of Drug Targeting OSA and Hypertension
The trial will evaluate the drug’s potential to reduce upper airway obstruction and nocturnal hypertension in patients with moderate-to-severe OSA.
Read More
Optical Imaging Could Bring Precision to Sleep Apnea Diagnosis
Optical imaging combines with computational fluid dynamics to provide precise 3D reconstructions of the upper airway, improving the detection and localization of obstructive sleep apnea.
Read More
AASM: Zepbound Approval for OSA a ‘Positive Development’
The AASM issued a statement in response to the FDA’s approval of Zepbound for OSA patients with obesity, highlighting its potential as a new treatment option while cautioning about its limitations and the importance of sustained weight loss.
Read More
Encrypted AI System Spots Sleep Apnea Without Privacy Risks
A new AI technique using fully homomorphic encryption achieved 99.56% accuracy in detecting sleep apnea while safeguarding patient data.
Read More
FDA Approves Zepbound for Sleep Apnea Patients With Obesity
The FDA has approved Zepbound as the first prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity.
Read More
Sleep Apnea Linked to Increased Brain Growth
Sleep apnea may lead to increased brain growth in the hippocampus, which could have implications for memory and cognitive function.
Read More
Eli Lilly’s Mounjaro Doesn’t Need Separate Approval for Sleep Apnea, Says EMA
The EMA has determined that Mounjaro’s existing weight management approval includes its benefits for treating obstructive sleep apnea, eliminating the need for a separate application for an OSA indication.
Read More
Adenotonsillectomy for Sleep-Disordered Breathing Not Linked to Weight Gain
The results of a clinical trial show no correlation between adenotonsillectomies and undesirable weight gain in children.
Read More
Most Providers Want GLP-1s Approved for Sleep Apnea, Barometer Finds
A global survey asked healthcare providers which condition they are most eager to see GLP-1 medications approved for, and sleep apnea emerged as the top choice.
Read More
Peer Support Boosts CPAP Adherence
Patients receiving peer mentorship used their CPAP machines more consistently, averaging 4.5 hours per night compared to 3.7 hours for those receiving standard care.
Read More
BodiMetrics and EnsoData Partner to Enhance Home Sleep Apnea Testing
BodiMetrics and EnsoData have partnered to enhance home sleep apnea testing and monitoring by integrating the EnsoSleep PPG software with BodiMetrics’ circul pro smart ring.
Read More
How Lincare Cashed In on the Disastrous Recall of Philips Breathing Machines — at the Expense of Patients
A report from ProPublica says that Lincare was supposed to supply the most ailing patients with new CPAPs but instead diverted the devices to new customers who would deliver greater profits for the company.
Read More
Fisher & Paykel Launches Its Lightest CPAP Mask in the US
Fisher & Paykel Healthcare has launched its F&P Nova Micro nasal pillows mask in the United States, the company’s lightest and smallest CPAP therapy mask to date.
Read More
High Temperatures Aggravate Sleep Apnea
Elevated temperatures were found to increase apnea events and reduce oxygen levels in patients with OSA on the same night, with effects disappearing the following day.
Read More
Sleep Apnea Contributes to Dementia Development
‘The results provide new evidence that clinicians and patients, when making decisions about testing for sleep apnea and treating it, should consider the possibility that untreated sleep apnea causes or exacerbates dementia.’
Read More